Analyst Insight by Cathy Boyle, Contributing Analyst, Euromonitor International
Despite the overall importance of
multinational operators in beverage supply, the industry has recently seen a
surge in the numbers of small- and medium-sized enterprises (SMEs) that are making
a name for themselves, often through innovation and diversification. For
ingredients suppliers looking to generate value, these SMEs are likely to become
an increasingly important customer base as they are often pioneers in the use
of new, premium and innovative ingredients.
This ever-increasing body of SMEs is cashing
in on consumers’ growing interest in more natural, healthy, traditional,
authentic and experimental beverages, usually at the premium end of the market.
They are particularly prominent in the developed regions of North America and
Western Europe and are impacting on both the soft drinks and alcoholic drinks industries.
As well as interest in healthy and functional ingredients, they also tend to be
highly innovative in their choices of flavouring and sweetening ingredients, as
discussed in the Global Report Beverage
Ingredients: Regional Insights.
Continue reading "Beverage SMEs Are a Growing Market for Innovative Ingredients" »
Analyst Insight by Simone Baroke, Contributing Analyst, Euromonitor International
A new study makes the point that reducing sugar intake is valuable in the global battle against obesity. Reduced-sugar packaged foods and drinks, however, are delivering a mixed performance. While reduced-sugar soft drinks have a high penetration in developed markets, they lag behind in emerging economies, and reduced-sugar packaged foods are delivering moderate growth at best. So, where do we go from here?
Continue reading "For the Sake of Public Health, Let’s Not Give Up on Reduced Sugar" »

Analyst Insight by Cathy Boyle, Contributing Analyst at Euromonitor International
The global beverage market of the modern
era is very different from that of the past, having moved way beyond the idea
of simple refreshment to become increasingly diverse and complex. This
situation is placing pressure on ingredients suppliers to satisfy the ever
evolving needs of beverage innovators, while at the same time facing their own
economic and sustainability challenges.
Perhaps the single most important theme in
beverage innovation in recent times has been the need for more naturally
healthy ingredients. For example, superfruit juices and flavours have taken
hold in soft drinks NPD in recent times, while more recently coconut water has
started to emerge as another botanical ingredient with significant potential.
Aloe vera is also benefiting from the drive towards natural health, while
energising botanicals are finding a place in the thriving energy drinks market.
Naturalness is also impacting on the development of flavour and colour
ingredients as product formulators look to exclude all artificial ingredients
from their recipes, while stevia’s emergence as a new force in the sweeteners
category is still largely centred on beverage applications and is opening doors
to the creation of reduced-sugar and reduced-calorie options with a natural
positioning.
Continue reading "Beverage Ingredients: Trends and Influences" »
Analyst Insight by Hope Lee, Senior Analyst - Beverages, Euromonitor International
There would be no shortage of interest in Lucozade and Ribena although both may look tired and be seen as having less of an impression on the global stage than other megabrands such as Gatorade and Red Bull.
Pharmaceutical giant GlaxoSmithKline is carrying out a strategic review of its Lucozade and Ribena consumer health brands, and a sell-off cannot be ruled out. The company has not stated specifically if both brands could go to one buyer or be sold separately. Euromonitor International believes that it makes sense for the two established brands to go to different companies as what they offer is very different. The two brands’ combined sales are worth around US$1.5 billion globally. When considering valuation multiples, various potential suitors have the sufficient clout to strike a deal.
Continue reading "Potential Suitors for GlaxoSmithKline’s Lucozade" »